NSC |
Compound |
Enrichment |
Correlation |
NSC 675000 |
Null |
0.0283958753782624 |
0.1452249 |
NSC 676772 |
Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arbinopyranosyl] ester |
0.0283958753782624 |
-0.19672775 |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.0283958753782624 |
-0.22082113 |
NSC 681239 |
Bortezomib |
0.0283958753782624 |
-0.079561482 |
NSC 684440 |
Null |
0.0283958753782624 |
0.36187484 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.0283958753782624 |
0.43171397 |
NSC 690970 |
Null |
0.0283958753782624 |
0.010895791 |
NSC 695941 |
6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate |
0.0283958753782624 |
0.27373996 |
NSC 697653 |
Null |
0.0283958753782624 |
0.21263249 |
NSC 698058 |
Null |
0.0283958753782624 |
0.14090949 |